Eikesdal HP - Search Results

1

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival.

Pedersen CA, Cao MD, Fleischer T, Rye MB, Knappskog S, Eikesdal HP, Lønning PE, Tost J, Kristensen VN, Tessem MB, Giskeødegård GF, Bathen TF. Pedersen CA, et al. Among authors: eikesdal hp. Breast Cancer Res. 2022 Jun 24;24(1):43. doi: 10.1186/s13058-022-01537-9. Breast Cancer Res. 2022. PMID: 35751095 Free PMC article.

2

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.

Schuster C, Eikesdal HP, Puntervoll H, Geisler J, Geisler S, Heinrich D, Molven A, Lønning PE, Akslen LA, Straume O. Schuster C, et al. Among authors: eikesdal hp. PLoS One. 2012;7(6):e38364. doi: 10.1371/journal.pone.0038364. Epub 2012 Jun 15. PLoS One. 2012. PMID: 22719881 Free PMC article. Clinical Trial.

3

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.

Lønning PE, Eikesdal HP. Lønning PE, et al. Among authors: eikesdal hp. Endocr Relat Cancer. 2013 Jun 24;20(4):R183-201. doi: 10.1530/ERC-13-0099. Print 2013 Aug. Endocr Relat Cancer. 2013. PMID: 23625614 Free PMC article. Review.

4

The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.

Austreid E, Lonning PE, Eikesdal HP. Austreid E, et al. Among authors: eikesdal hp. Expert Opin Pharmacother. 2014 Apr;15(5):681-700. doi: 10.1517/14656566.2014.885952. Epub 2014 Feb 28. Expert Opin Pharmacother. 2014. PMID: 24579888 Review.

5

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.

Eikesdal HP, Knappskog S, Aas T, Lønning PE. Eikesdal HP, et al. Acta Oncol. 2014 Oct;53(10):1347-55. doi: 10.3109/0284186X.2014.922215. Epub 2014 Jun 9. Acta Oncol. 2014. PMID: 24909504 Free PMC article.

6

Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy.

Kim J, de Sampaio PC, Lundy DM, Peng Q, Evans KW, Sugimoto H, Gagea M, Kienast Y, Amaral NSD, Rocha RM, Eikesdal HP, Lønning PE, Meric-Bernstam F, LeBleu VS. Kim J, et al. Among authors: eikesdal hp. JCI Insight. 2016 Dec 22;1(21):e90733. doi: 10.1172/jci.insight.90733. JCI Insight. 2016. PMID: 28018977 Free PMC article.

7

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.

Yndestad S, Austreid E, Knappskog S, Chrisanthar R, Lilleng PK, Lønning PE, Eikesdal HP. Yndestad S, et al. Among authors: eikesdal hp. Breast Cancer Res Treat. 2017 May;163(1):177-190. doi: 10.1007/s10549-017-4160-5. Epub 2017 Feb 17. Breast Cancer Res Treat. 2017. PMID: 28213783 Free PMC article.

8

Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines.

Yndestad S, Austreid E, Svanberg IR, Knappskog S, Lønning PE, Eikesdal HP. Yndestad S, et al. Among authors: eikesdal hp. Oncotarget. 2017 Jun 20;8(25):41227-41241. doi: 10.18632/oncotarget.17167. Oncotarget. 2017. PMID: 28476032 Free PMC article.

9

Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer.

Yndestad S, Austreid E, Skaftnesmo KO, Lønning PE, Eikesdal HP. Yndestad S, et al. Among authors: eikesdal hp. Mol Cancer Res. 2018 Jan;16(1):78-89. doi: 10.1158/1541-7786.MCR-17-0207. Epub 2017 Oct 11. Mol Cancer Res. 2018. PMID: 29021233

10

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Lønning PE, Eikesdal HP, Løes IM, Knappskog S. Lønning PE, et al. Among authors: eikesdal hp. Cell Stress. 2019 Mar 22;3(4):118-135. doi: 10.15698/cst2019.04.183. Cell Stress. 2019. PMID: 31225507 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page